>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • NUS -23.4% (also lowers dividend), OTLY -22.9%, HLF -21%, FSLY -20.7%, AUPH -20.1%, WST -15.7%, UDMY -13.6% (also authorizes new $100 mln share repurchase program), YETI -12.4%, TWLO -11.2%, NRDS -9.4%, MTW -8.8%, ZCAR -8.6%, SPTN -7.2%, HCC -6.6%, ADPT -6.3%, PBF -6.2%, ROL -6%, GPC -5.6%, PENN -4.4%, CSCO -4.3% (also announces restructuring plan; will impact 5% of workforce; also increases dividend), TYL -4.3%, ARCH -4.3%, ALB -4%, IRWD -3.7%, DE -2.8%, TRGP -2.6%, VECO -2.3%, VTR -1.8%, WEN -1.6%, NMIH -1.1%, QS -1% (also names new CEO), CGNX -0.9%, HOUS -0.9%
Other news:
  • AGYS -5.8% (prices secondary offering of 867729 shares of its common stock by certain investment funds resulting in gross proceeds to the selling stockholders of $72.7 mln)
  • PRME -4.6% (prices upsized offering of common stock and warrants)
  • HHH -1.8% (Bill Ackmann increases stake)
  • BHP -1.8% (will recognize a non-cash impairment charge of approximately $2.5 billion (post tax) (approximately $3.5 billion pre-tax) against the carrying value of Western Australia Nickel)
  • IWR -1.3% (Starboard Value discloses increased position)
  • GOOG -1.2% (OpenAI to develop web search product to challenge GOOG according to The Information)
  • DHI -1.2% (Berkshire Hathaway exits position)
  • BVN -0.9% (Q4 production and volume results)
Analyst comments:
  • CLF -1.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • KEYS -1.2% (downgraded to Neutral from Overweight at JP Morgan)
  • GNRC -0.7% (downgraded to Neutral from Buy at Guggenheim)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • APP +22.7% (also increases share repurchase authorization by $1.25 bln), INFA +19.8%, FROG +18%, RS +15.4%, PEGA +14.8%, APPN +13.6%, AMWL +10.8%, SHAK +10.2%, ATUS +9.3%, CLBT +8.5%, ZBRA +7.9%, SUM +6.6%, EPAM +6.5%, PTEN +5.5%, CBRE +5.3%, ALKS +5.3%, PGRE +5.1%, TRIP +4.9%, STLA +4.7%, RPTX +4.4%, SLVM +3.9%, GEO +3.8%, AR +3.7%, MFC +3.4% (also increases dividend), KAI +3%, HUBS +2.9%, PLMR +2.9%, CROX +2.4%, ROIC +2.3%, EPRT +2.3%, WD +2.2%, NVMI +2.1%, UPWK +2%, IRDM +1.9%, EQIX +1.8%, NTST +1.8%, CRBG +1.8%, ARR +1.8% (guidance), DNOW +1.8%, HL +1.7%, AM +1.7% (also authorizes new $500 mln share repurchase program), FCPT +1.7%, OTIS +1.7%, KNF +1.6%, AWK +1.5%, LECO +1.5%, CF +1.2%, SN +1.2%, GTX +1.2%, CW +1.1%, MSA +0.9%, ORAN +0.9%
Other news:
  • SOUN +83.6% (NVDA discloses stake in SOUN)
  • SPWR +24.1% (secures additional capital to drive ongoing transformation)
  • PLCE +20.7% (provides shareholder update)
  • KALV +16.7% (pricing of a $160.1 mln public offering of common stock and pre-funded warrants)
  • APLT +10.4% (interim 12-month results from the ongoing Phase 3 INSPIRE trial)
  • DWAC +7.2% (announced effectiveness of Form S-4 Registration Statement for the proposed business combination with Trump Media & Technology Group)
  • GRPN +4.6% (prepaid approximately $43.1 million to terminate commitments to extend further credit)
  • SIRI +3.3% ( Berkshire Hathaway increases stake)
  • CPA +2.4% (reports Jan traffic data)
  • BKKT +1.9% (registration statement declared effective by the SEC)
  • DYN +1.5% (announces upcoming presentations on trials)
  • REVG +1.5% (prices secondary offering of 16.0 mln shares of common stock at $16.50 per share)
  • DNA +1.3% (Ginkgo Bioworks and SaponiQx (a subsidiary of AGEN) awarded MCDC Contract to discover and manufacture next-generation vaccine adjuvants using generative molecular design)
  • MESO +1% (receives Orphan-Drug Designation for Revascor from FDA)
  • CI +1% (will repurchase $3.2 bln of common stock through accelerated stock repurchase agreements with Deutsche Bank AG and Bank of America N.A.)
Analyst comments:
  • COIN +8.2% (upgraded to Neutral from Underweight at JP Morgan)
  • INGN +5.5% (upgraded to Outperform from Mkt Perform at William Blair)
  • TER +3.3% (upgraded to Neutral from Underweight at JP Morgan)
  • INGR +1.8% (upgraded to Buy from Neutral at Goldman)
  • APD +1.7% (upgraded to Buy from Neutral at BofA Securities)

>>> US Research Calls

Research Calls
  • Upgrades:
    • Air Products (APD) upgraded to Buy from Neutral at BofA Securities; tgt $264
    • Coinbase Global (COIN) upgraded to Neutral from Underweight at JP Morgan; tgt $80
    • Eversource Energy (ES) upgraded to Buy from Neutral at Mizuho; tgt raised to $62
    • Ingredion (INGR) upgraded to Buy from Neutral at Goldman; tgt raised to $135
    • Inogen (INGN) upgraded to Outperform from Mkt Perform at William Blair
    • Medpace (MEDP) upgraded to Buy from Neutral at UBS; tgt raised to $452
    • Molina Healthcare (MOH) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $420
    • Principal Fincl (PFG) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt $75
    • Similarweb (SMWB) upgraded to Buy from Neutral at Citigroup; tgt raised to $10
    • Teradyne (TER) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $100
  • Downgrades:
    • Akamai Tech (AKAM) downgraded to Reduce from Hold at HSBC Securities; tgt lowered to $96
    • Cleveland-Cliffs (CLF) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $20
    • Comcast (CMCSA) downgraded to Neutral from Buy at Redburn Atlantic; tgt lowered to $44
    • Charles River (CRL) downgraded to Neutral from Buy at Guggenheim
    • Generac (GNRC) downgraded to Neutral from Buy at Guggenheim
    • IQVIA (IQV) downgraded to Neutral from Buy at Guggenheim
    • Keysight (KEYS) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $170
    • Owens Corning (OC) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $154
    • Snowflake (SNOW) downgraded to Hold from Buy at HSBC Securities; tgt raised to $214
    • Sony (SONY) downgraded to Neutral from Outperform at Macquarie
    • SSR Mining (SSRM) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $6
    • U.S. Steel (X) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $51
    • Wabtec (WAB) downgraded to Neutral from Buy at Redburn Atlantic; tgt $135
  • Others:
    • Alnylam Pharma (ALNY) initiated with a Peer Perform at Wolfe Research
    • Alpine Immune Sciences (ALPN) initiated with an Outperform at Wolfe Research; tgt $44
    • argenx (ARGX) initiated with a Peer Perform at Wolfe Research
    • CervoMed (CRVO) initiated with a Buy at Canaccord Genuity; tgt $50
    • Cisco (CSCO) resumed with an Equal Weight at Wells Fargo; tgt $52
    • CRISPR Therapeutics (CRSP) initiated with a Peer Perform at Wolfe Research
    • Cullinan Management (CGEM) initiated with an Outperform at Wedbush; tgt $30
    • Deckers Outdoor (DECK) initiated with an Outperform at Evercore ISI; tgt $960
    • Dianthus Therapeutics (DNTH) initiated with a Buy at Stifel; tgt $44
    • Eastman Chemical (EMN) initiated with a Buy at Redburn Atlantic; tgt $110
    • Elastic (ESTC) initiated with a Sector Outperform at Scotiabank; tgt $185
    • GE HealthCare (GEHC) initiated with a Buy at HSBC Securities; tgt $100
    • i3 Verticals (IIIV) added to DA Davidson's Stampede List
    • Immunovant Sciences (IMVT) initiated with an Outperform at Wolfe Research; tgt $55
    • Insmed (INSM) initiated with an Outperform at Wolfe Research; tgt $42
    • Intellia Therapeutics (NTLA) initiated with a Peer Perform at Wolfe Research
    • JELD-WEN (JELD) initiated with a Hold at Loop Capital; tgt $22
    • Kymera Therapeutics (KYMR) initiated with a Peer Perform at Wolfe Research
    • MoonLake Immunotherapeutics (MLTX) initiated with an Outperform at Wolfe Research; tgt $77
    • Monte Rosa Therapeutics (GLUE) initiated with an Outperform at Wedbush; tgt $11
    • RAPT Therapeutics (RAPT) initiated with an Outperform at Wolfe Research; tgt $39
    • Roivant Sciences (ROIV) initiated with an Outperform at Wolfe Research; tgt $17
    • Savara (SVRA) initiated with a Mkt Outperform at JMP Securities; tgt $8
    • Skechers USA (SKX) initiated with an Outperform at Evercore ISI; tgt $73
    • Super Micro Computer (SMCI) initiated with a Buy at BofA Securities; tgt $1040
    • Vertex Pharma (VRTX) initiated with an Outperform at Wolfe Research; tgt $515

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • SOUN +73.4%, APP +22.7%, INFA +19.5%, FROG +18%, PEGA +13.7%, KALV +12.6%, SUM +6.6%, ATUS +6.5%, DWAC +6.1%, TRIP +6.1%, PGRE +5.1%, MFC +5%, PTEN +4.4%, GEO +4.4%, STLA +4.2%, SIRI +4%, AMWL +3.6%, KAI +3%, BKKT +2.9%, HUBS +2.9%, PLMR +2.9%, EPAM +2.8%, CPA +2.4%, UPWK +2.3%, ROIC +2.3%, EPRT +2.3%, WD +2.2%, NMIH +2.1%, TRGP +1.9%, CVE +1.9%, NTST +1.8%, AR +1.7%, FCPT +1.7%, OTIS +1.7%, MESO +1.6%, KGC +1.6%, DYN +1.5%, HL +1.5%, GRPN +1.3%, EQIX +1.2%, CF +1.2%, CW +1.1%, ORAN +1.1%, AM +1%, CI +0.9%, MSA +0.9%, AWK +0.9%
  • Gapping down:
    • NUS -24.3%, FSLY -21.4%, ADPT -15.2%, AUPH -14.3%, TWLO -12.1%, HLF -11.2%, UDMY -10.8%, ZCAR -9.7%, MTW -9.4%, NRDS -9.4%, YETI -8.7%, ROL -7.8%, PRME -7.4%, HCC -6.1%, AGYS -5.2%, CSCO -4.7%, ALB -4.7%, TYL -4.6%, DE -3.1%, QS -2.7%, BHP -2%, HHH -1.8%, VECO -1.6%, REVG -1.4%, GOOG -1.3%, IWR -1.3%, DHI -1%, BVN -0.9%, FUN -0.8%

>>> Temenos: Major Accounting Irregularities, Failed Products And An Illusive Tu

Temenos: Major Accounting Irregularities, Failed Products And An Illusive Turnaround


(SWX:TEMN)
  • Temenos AG is a ~$7.5B market cap Swiss-listed banking software developer and services company that serves 3,000 customers globally and reported $1 billion in preliminary 2023 revenue.
  • Our 4-month investigation into Temenos, involving interviews with 25 former employees, including senior leaders at the company, uncovered hallmarks of manipulated earnings and major accounting irregularities. This includes evidence of roundtripped revenue, sham partnerships, rampant pulling forward of contract renewals, backdated contracts, excessive capitalization of seemingly non-existent R&D investments, and other classic accounting red flags.
  • These aggressive accounting practices seemed to be an open secret among many of the former employees we spoke with. Several indicated that CEO Andreas Andreades encourages the practices, which help gloss over significant customer product dissatisfaction and attrition.
  • In October 2021, Temenos announced a strategic partnership with fintech Mbanq to “accelerate banking-as-a-service adoption across the US,” its key strategic market. According to a former Temenos executive, the deal involved Mbanq purchasing $20 million in software and services from Temenos.
  • Litigation records, financial statements, and former Temenos executives evidence that Temenos secretly funded the purchase of its own software- effectively engaging in a roundtripping scheme by making an undisclosed ~$20 million investment into Mbanq around the same time as the software purchase.
  • A former Temenos executive told us, “The convertible note was signed the same day, the same hour as the deal was signed for Mbanq … because they [Mbanq] couldn’t have signed it if they didn’t have the money.” They added, “If that was in the US and that was with the SEC, everyone would be out.”
  • In February 2021, Temenos announced a partnership with US-based banking software company DXC Technology, which a former DXC executive told us entailed DXC buying approximately $8-10 million in software licenses from Temenos.
  • While Temenos repeatedly assured shareholders that the DXC partnership was “game-changing” and would “accelerate our penetration” with large banks in North America, a former DXC executive told us the deal was “rushed through” on the last day of the year to “help Temenos make their yearly number”. They said of the deal: “This isn’t a partnership. You used us for a license sale.”
  • According to the executive, the deal was subsequently terminated due to inaction on Temenos’ part, leading to an eventual ~$8 million write-off for DXC, saying “they [Temenos] left us at the altar … we gave them a bunch of money and then they literally walked away.”
  • A former Temenos executive confirmed that the partnership failed, saying, “[DXC] had to write that off [their] books…” and told us the deal was “typical Temenos” and all about “selling and quick hits.”
  • Throughout our research, 4 different former Temenos employees corroborated the practice of pulling forward license renewals, often at discounts, to boost short-term earnings while cannibalizing future renewal revenue. One former executive told us, “If there’s a renewal that they can pull forward, they’re going to go and be very aggressive about doing that, and that’s what happened.”
  • Another executive described the effect of aggressive pull forwards by citing Temenos’ record-breaking revenue in 2019, saying, “When outside investors were looking at this, they thought ah, the licensing is growing and we’re getting new customers. The reality is the new customer sales were coming down…”
  • When asked about pulling forward renewals, a former salesperson simply told us, “I just thought, you know what... there’s going to be some accounting scandal at some point…”
  • A former Temenos executive told us that the company also regularly backdated contracts to shift earnings to earlier quarters, saying, “… the standard practice, which was known completely and condoned by Andreas and Max [current and former CEOs], but denied in public, was that the legal teams would give power of attorney to the sales teams to backdate a deal that had come in, you know, after the end of the quarter.”
  • A former sales leader from Temenos corroborated the practice of backdating, saying, “Don’t trust any of the public information … including the analyst call, okay? … I’ve seen deals closed in January that they were pulled back to the previous quarter, okay? They do that.”
  • Temenos states that it invests 20% of its revenue back into R&D, “more than twice the level” of its closest competitors. Former senior Temenos executives told us the advertised R&D spend was “non-existent” and a “mystery.”
  • One former Temenos executive told us the majority of Temenos reported R&D investments were actually customer-specific implementation costs: “All you’re doing is just taking something that was custom for a customer and saying it’s R&D. It’s not. That’s the majority of it.”
  • In 2022, Temenos’ R&D capitalization rate was 62% higher than peers, resulting in an estimated $86 million of already questionable R&D costs being shifted to the balance sheet. Compared with the peer average capitalization rate, Temenos’ capitalization led to an estimated 29.5% artificial boost to its 2022 pre-tax profits.
  • In 2023, Temenos extended its allowable amortization period for “internally generated software development costs” from 5 years to 7 years, allowing it to recognize these capitalized costs even more slowly than before, with zero disclosure about its impact on its financials. We estimate the change will allow Temenos to artificially boost 2023 profits by up to 8.7%.
  • Temenos also has almost double the Days Sales Outstanding (DSO) of its closest peers at 124 days, a classic sign of aggressive revenue recognition policies and difficulty collecting on reported revenue.
  • Despite the Mbanq and DXC partnerships seemingly failing to yield new business in North America, Temenos continues to highlight the region as its key strategic market and driver of growth, projecting it will soon account for 45-50% of software licensing revenue due to Temenos’ “leadership vision” and “superior technology.”
  • Our research uncovered a series of failed implementations and frustrated customers in North America. One former Temenos executive said, “Clients were falling out the bottom of the funnel, so to speak, as fast as we could fill it at the top” due to CEO Andreades refusing to look at “deficiencies in the product…”
  • Another former Temenos employee said Andreades would often pitch non-existent products to prospective customers, telling us “Andreas or (former CEO) Max would be going into a meeting and they didn’t have a brochure for the feature that didn’t exist… and it had to be on their desk by the time they got to the client. For a feature that hasn’t been thought of, not run by product, not run by anybody sensible…”
  • US-based Unify Financial Credit Union signed on with Temenos in September 2018. It sued Temenos for fraudulent inducement and negligent misrepresentation by December 2021, claiming that Temenos oversold its cloud capabilities and that its software was so unstable that Unify had to revert to its old system 2 months after going live.
  • US-based First Fidelity Bank signed on with Temenos in December 2019. It sued Temenos for breach of contract and fraudulent misrepresentation in 2022, saying it was “fed up with Temenos’ excuses and delays.”
  • US-based Grasshopper Bank went live with Temenos’ core software in 2019, only to abandon it 4 years later after numerous implementation issues. A former executive from Grasshopper told us that its entire new bank launch was put on hold “largely because of Temenos’ implementation strategy”, which they described as “excruciating”.
  • US-based Varo Bank went live with Temenos’ core banking software in September 2020, and is currently highlighted as a “success story” on Temenos’ website. Former Varo employees described the implementation as a “horrible experience” that left them “forever scarred.”
  • One former Varo executive told us, “Nothing was out of the box, even though everything was sold as out of the box” and that “literally nothing worked.” The executive claimed that Varo took millions in losses due to issues with the Temenos implementation.
  • In 2019, Temenos formally announced “Temenos Infinity,” an attempt to diversify beyond core banking software by rolling $840 million of acquisitions into a new division focused on “digital banking” products. As recently as its 2023 Capital Markets Day presentation, Temenos has continued to tout Infinity as a successful entry into digital banking that represents an addressable market as large as core banking.
  • Former Temenos executives, partners, and customers confirmed dozens of failed Infinity implementations, with one former Temenos executive calling the entire division “a huge destruction in value”, saying that “a whole Infinity team of 20 or 30 salespeople” got “canned.” A second former employee confirmed that Temenos “axed pretty much everybody in Infinity” over the last year. A third said “the top talent that supported that product [Infinity] left.”
  • A former Temenos executive told us that the great majority of North American Infinity implementations simply failed, saying, “Let’s see, in 2021, we had 19 clients in North America… that were supposed to go live [on Infinity], and 2 of those 19 went live… tons of client cancellations, frustrated, angry clients.”
  • We also found evidence of failed Infinity projects in the Middle East, Asia, and Australia. We spoke with a former manager from NDC Tech (now Systems Limited), one of Temenos’ implementation partners in the MENA region. They also confirmed widespread Infinity failure, saying, “… around 20+ banks in 3 years onboarded with Infinity … but honestly, out of those 20+ banks, only 2 or 3 banks were able to go live.”
  • Finally, we were told by a former senior Temenos executive that CEO Andreades admitted in a closed door meeting that Infinity had failed. The executive said, “He [Andreades] literally said… we’ve gotten nowhere with Infinity in 3 years, we need to just, you know, toss it overboard [and] be done with it.”
  • Many of Temenos’ most highlighted deals in Europe and Australia have been plagued with delays, cost overruns, and regulatory issues, despite Temenos’ posturing to the market that the deals have been major successes.
  • In 2015, Nordea signed on for what was supposed to be a 5-year core banking transformation with Temenos, representing the largest deal in Temenos history to that point. Today, the deal is touted as a success story by Temenos.
  • However, Nordea reportedly experienced cost overruns, delays, and its Chief Banking Officer resigned in May 2021 amidst reports that the bank’s core banking transformation had slowed. A former Temenos executive called the implementation "absolutely terrible” and confirmed that the Nordea transformation was still ongoing nearly 9-years after kick-off.
  • In 2016, the Bank of Ireland selected Temenos to be “at the heart” of its €500 million technological transformation. The project budget reportedly tripled over 5 years, led to wide-ranging IT failures and a $139 million impairment for the bank.
  • A former IT manager from the Bank of Ireland told us Temenos over-promised and under-delivered, saying Temenos’ software “couldn’t handle” the bank’s needs. The former manager said that the Temenos team was sometimes more focused on “just trying to sell more software…”
  • In May 2018, Australia-based BNK Banking announced it had gone live with Temenos’ cloud banking software, but in July 2023, BNK was hit with 18 infringement notices from Australia’s banking regulator due to flaws in Temenos’ software, per a BNK spokesperson to the media.
  • BNK is now leaving Temenos mid-contract according to an Australian banking consultant familiar with the company who told us, “Honestly, an Excel sheet would work better than Temenos, and that’s being gentle. It is horrendous … they have cost [BNK] what we believe to be over $100 million worth of lost opportunity.”
  • An Australian banking consultant that worked on Temenos implementations summed up his view of Temenos as a “just a fantastic sales company and just a sales machine, but honestly can’t back it up with anything… the most difficult vendor I’ve ever come across. They promised us the world. It was all vaporware, basically…”
  • While institutions like Baillie Gifford, Fidelity and Fundsmith, have accumulated significant positions, Temenos executives have dumped $1.1 billion in stock over the last 10 years, per Bloomberg.
  • Temenos trades at a fundamental premium to its peers, representing significant downside even if one were to ignore all the findings of our report. Consensus estimates show it trades at a 76% earnings premium, a 41% EV/revenue premium, and a 59% EV/EBITDA premium.
  • In its quest to seemingly do just about anything to prop up its earnings and boost its stock price, Temenos finds itself on the classic accelerating accounting treadmill. We expect it will soon run out of accounting tricks, new unwitting customers who believe its glossy sales pitches, and new investors willing to buy as executives continue to sell.
  • Temenos says it “takes every step to be as open and forthcoming as possible with data” and that it will fully investigate claims of “concerns or improper conduct.” With this commitment to transparency in mind, we have included 36 questions at the end of this report.
Initial Disclosure: After extensive research, we have taken a short position in shares of Temenos AG (SWX:TEMN). This report represents our opinion, and we encourage every reader to do their own due diligence. Please see our full disclaimer at the bottom of the report.

FT : Can OpenAI create superintelligence before it runs out of cash?

Can OpenAI create superintelligence before it runs out of cash?
The AI start-up is one of the fastest-growing companies in history, but questions remain about the long-term viability of its business model

On the morning of November 18, during a tech conference in Tokyo, Ting Cai received a news alert about OpenAI’s Sam Altman, who had been ousted in a boardroom coup.

Cai, chief data officer of Japanese tech giant Rakuten, was caught off guard. He had flown back from San Francisco days earlier, where he had recently seen the chief executive of the artificial intelligence pioneer and his team, with whom Rakuten had been collaborating on a new AI business platform.

Straight away, the Japanese executive was reassured by OpenAI’s senior management that there had been no wrongdoing on Altman’s part, and Rakuten decided to keep faith in its partnership with OpenAI. Three days later, Altman was reinstated, under a new board. “It was difficult times for them, but our bond and relationship is even stronger,” Cai says.

Rakuten was not alone in standing firm behind OpenAI’s business, despite ructions at the top of Silicon Valley’s hottest start-up. In December, OpenAI’s revenues surpassed $2bn on an annualised basis, making it one of the fastest-growing technology companies in history.

Since the launch of its viral chatbot ChatGPT in late 2022, OpenAI has built up a business that is among a handful of Silicon Valley companies, including Google and Meta, to have posted revenues of $1bn within a decade of being founded.

The Microsoft-backed company believes it can more than double its yearly run rate — a measure of the most recent month’s revenue, multiplied by 12 — in 2025. The company’s enterprise tools, built on generative AI models that are capable of producing text, code and images, have been bought by finance, media and technology giants ranging from Morgan Stanley to Axel Springer, Salesforce and Rakuten.

According to Altman, 92 per cent of Fortune 500 companies use OpenAI products, which include ChatGPT and its underlying AI model GPT-4, while ChatGPT has 100mn weekly users.

While the company has accelerated the pace of its sales growth in the past year, its valuation has also risen exponentially from roughly $29bn last April to $86bn in October, premised on its future moneymaking potential. Investors are betting that consumer and business interest in generative AI will continue to climb in the coming year, as people are eager to experiment with the technology.

Satya Nadella, chief executive of Microsoft, which is OpenAI’s biggest backer, said last month: “This is . . . about intelligence, expertise at your fingertips . . . that’s the era we are in. Twenty twenty-four is the year all of this will scale.”

But as OpenAI enters its year of rapid growth, questions about the long-term viability of its business model remain. Altman and Nadella have both said they believe generative AI will significantly accelerate global productivity and economic growth, accruing wealth broadly along the way, which can be continuously invested into its further development. Altman’s stated goal is to build “artificial general intelligence”, a form of intelligent software that would supersede human intellectual capabilities, which would change how we all live and work.

However, many companies are yet to figure out how to integrate generative AI into their processes, or estimate what kinds of cost and productivity benefits it might bring. And even as demand grows, Open AI’s advantage as the first mover is shrinking as tech giants such as Google and Meta work furiously to catch up.

“OpenAI is throwing a lot of stuff at the wall to see what sticks,” says Ethan Mollick, a professor at Wharton Business School, who focuses on AI and innovation. “They have a typical start-up identity crisis happening: on one hand they could build a profitable business, wind down their R&D costs and make improvements to their product. Or keep going for this absolute moonshot, where the world changes.”

Meanwhile, the costs of training and running large language models, such as OpenAI’s GPT-4, remain eye-wateringly steep. Altman has suggested it could cost in the order of a trillion dollars to develop AGI, largely due to the infrastructure and data required to train more sophisticated models.

For now, investors and analysts remain focused on the more immediate question of where returns on investment will come from, and whether OpenAI can sustain long-term growth while its spending vastly outpaces sales. In other words, can OpenAI create valuable superintelligence before it runs out of cash?

OpenAI was founded in 2015 as a not-for-profit research lab. Its mission then was to create superintelligent AI that benefits humanity.

While Altman claims this is still OpenAI’s guiding principle, the company has turned into a fast-growing business under his leadership. Altman, the former president of Silicon Valley start-up accelerator Y Combinator, is described by one AI investor as a “prototypical venture capitalist” — someone exceptionally good at spotting momentum early and capitalising on it.

Led by chief operating officer Brad Lightcap, OpenAI has built revenue streams around two main products: the company’s calling card ChatGPT and the underlying model GPT-4.

Businesses can pay for subscriptions to ChatGPT through ChatGPT Team, which costs between $25-$30 per user per month and can be used by smaller teams. ChatGPT Enterprise, aimed at teams larger than 150 people, has stronger security and privacy protections and can only be bought via an annual subscription.

ChatGPT Enterprise now has more than 300 paying customers. Lightcap tells the FT that this stream will be a “tremendous driver of growth for us over the next few years” and that the self-reported gains in productivity from customers were “huge multiples, not small per cents”.

OpenAI also charges companies to access its most advanced model GPT-4, via an application programming interface, or API. It recently launched a GPT Store to its subscribers, who can build apps on top of OpenAI’s software, in a similar way to Apple’s iOS App Store — although there is no way yet to make money from it.

“The theme of the past year has been a kind of awakening, that these models are really quite powerful,” says Lightcap. “A lot of where we’re pushing is trying to give people enterprise grade tools . . . and then giving them ways to build on top of that, to customise it.”

OpenAI has relentlessly expanded its product partnerships, while slashing costs to developers as it seeks to sustain its advantage over more established rivals such as Google, as well as a wave of new companies such as Mistral that are building open-source models to compete with GPT-4.

Some companies say the AI models have had marked effects on their businesses. Enterprise tech giant Salesforce, for example, says its clients are seeing significant results in the area of customer service. Clara Shih, chief executive of Salesforce AI, says clients had found that using Einstein, the tool the company originally partnered with OpenAI to build for business customers, had driven down average call handle times by double digits and materially improved customer satisfaction scores. The tool now allows customers to plug in models from other AI companies too.

“You can use this to cut costs, but in practice, from companies like Gucci, we see that they can redeploy their customer service representatives to become brand and product storytellers . . . and do sales,” Shih says. “It’s been really promising.”

DoNotPay, an online legal service, has used OpenAI tools in developing its chatbot that helps customers contest fines such as parking tickets or bank fees. Founder Joshua Browder says OpenAI lowering its prices was “transformative to consumer companies” like his, and says DoNotPay is now spending more on AI services than on cloud hosting for its website and data. “We think [the tools are] second to none in terms of cost and usefulness against other models,” he says.

But although there has been enthusiastic take-up of AI models in the short-term, many business leaders remain unsure of how the technology will lift their bottom lines, whether through cutting costs or creating new revenue streams.

“Everyone’s done a proof of concept. Every CEO has got the account,” says Benedict Evans, a former investor at venture capital firm Andreessen Horowitz who is now an independent technology analyst. “But there’s a second step, which is, ‘How does this actually change how you do things?’”

A member of Lightcap’s team concurs with this view, saying that most enterprises remained in the experimentation phase with OpenAI’s products, working out where they might add value before deciding whether to roll them out across the whole organisation.

The chief financial officer at one multibillion-dollar business says that, while most of his peers were using ChatGPT in some way, it was often at the margins of their business and he was surprised at how little they were actually paying OpenAI. “You see people spending $100 and $1,000, it’s not like people spend on AWS,” he says, referring to Amazon’s web hosting business.

But even as this process is ongoing, rivals are circling. Competitors such as Google, Anthropic and Meta have spent billions developing their own models and are now focusing on creating clear business models from the software.

Last week, Google announced a premium subscription plan costing $20 a month for use of its most capable model, Gemini Ultra, which early users claim is indistinguishable from OpenAI’s GPT-4. It joins start-ups such as Cohere, Anthropic and Mistral who are all selling AI models to businesses ranging from banks and media organisations, to law firms and management consultancies.

“[OpenAI] are now first among equals, as opposed to being unfathomably miles ahead of everybody else,” says Evans.

The quality of the company’s next model will determine how it fares against rivals. “Everything depends on GPT-5. If they don’t have a technological lead, their advantage is much lower,” Mollick said.

The start-up will also have competition even closer to home: with Microsoft, which is entitled to 49 percent of profits from its for-profit subsidiary. Microsoft has rolled out Copilot, an AI productivity assistant, in its suite of productivity apps, which includes Word, PowerPoint and Excel, for $30 a month.

Copilot runs on OpenAI’s technology, and the start-up has a profit-sharing agreement with its investor on any sales made through its platforms. Customers can buy OpenAI’s software either directly from the company, or via Microsoft and its Azure platform.

While Microsoft has not disclosed sales or user figures for Copilot, the company said in October that 18,000 customers were buying OpenAI software through its Azure platform. OpenAI receives a portion of revenue via Microsoft sales of its products, but it keeps a larger share from direct sales, according to The Information, a technology news site.

Customers who opt to use OpenAI’s tools via Microsoft say they do so for greater security of data and because their internal software is already integrated with Microsoft’s products.

“Copilot offers us a more connected customer view, which in turn allows us to build more integrated experiences for our brands,” says Jessica Tamsedge, UK chief executive of Dentsu Creative, a creative agency which became one of the first customers of Microsoft Copilot. “OpenAI is more siloed in how it holds data and plays back to the advertiser or enterprise.”

But businesses that work directly with OpenAI describe a relationship where they are less a customer than a co-developer. Cai, of Rakuten, says the partnership spanned multiple levels, including with OpenAI’s product and business teams as well as with Altman and Lightcap.

“When you want to bring your technology to billions of customers and lots of business partners, you need to apply it to real products,” he says. “This is where Rakuten is interesting to them — we have channels to reach 70 different businesses . . . in shopping, travel, medical, financial services, Rakuten Mobile. So it is very complementary.”

Cai said that the relationship included “mutually beneficial economic opportunities” and that the two teams communicated in Slack and brainstormed “new business models and product ideas”.

Beyond its direct competitors, OpenAI will have to take on a generation of new companies that will race to build specialist applications on top of the range of available AI models. Analysts like Evans believe customers will look to buy these enterprise-friendly and targeted products, rather than use generalist AI software like ChatGPT for all their needs. He says: “My . . . thesis is this will get unbundled [into] lots and lots of different products.”

Sceptics say there is a fundamental misalignment between what companies want and what OpenAI is ultimately aiming for. “Not everyone needs a Ferrari . . . [enterprises] don’t care about an all knowing, all seeing entity: they care about making money from this tool,” says one AI investor who has backed some of OpenAI’s rivals. “The mundane objectives of a corporation are misaligned with artificial general intelligence.”

The revenue from clients is not likely to make a significant dent in OpenAI’s enormous capital requirements as it gears up to launch its next-generation model GPT-5 in the coming year, and pursue its longer-term goal of creating AGI.

Altman and others have given estimates of the cost of building out AI infrastructure varying from the hundreds of billions of dollars to as high as $7tn over coming years. Whatever the number, the need for cash will oblige the company to seek new funding from existing backers such as Microsoft and new investors with even deeper pockets.

With OpenAI’s current valuation already approaching $100bn, traditional venture investors, whose business is taking early bets on companies with huge growth potential, are largely priced out.

Edward Stanley, European head of thematic research at Morgan Stanley, questioned whether jumping into private AI companies was a smart decision for investors focused on tangible returns on their investment.

Vince Hankes, a partner at Thrive Capital, one of OpenAI’s biggest venture backers, says he and his team invested well over $100mn into OpenAI last year because they believe ChatGPT will be the dominant technology in a “winner takes all market”.

Sovereign wealth funds and nation state-backed investors are one possible avenue for fresh capital. Altman has spoken with investors in the Middle East including Sheikh Tahnoon bin Zayed al-Nahyan, one of Abu Dhabi’s wealthiest and most influential figures, about a new venture to secure OpenAI’s pipeline of semiconductors. These could lower the company’s costs dramatically and reduce its dependence on chip designer Nvidia.

In the short term, OpenAI must think small in order to buy time to get investors and customers to see the bigger picture. Lightcap says his team’s focus is not just on selling its products into enterprises, but also on building its own micro-versions of solutions to challenges businesses identify internally.

Altman’s longer-term goal, meanwhile, will be convincing consumers and corporations to believe in — and eventually finance — his grandiose vision of building superintelligent AI. Altman says: “I think the unbelievable abundance that will come from massively capable and massively available intelligence, what that will do to everyone’s quality of life . . . there’s a moral imperative to do that.”

FT : Renault and Stellantis to increase costs cuts in ‘turbulent year’

Renault and Stellantis to increase costs cuts in ‘turbulent year’
Carmakers’ shares rise on increased returns to investors but face lower margins due to electric vehicles

Carmakers Stellantis and Renault both warned of the need for cost cuts despite rising profits, as the industry heads into a “turbulent year” of economic and political uncertainty, and lower margins from pivoting to electric vehicles.

Shares in both groups rose on Thursday morning after Renault raised its dividend and Stellantis announced a €3bn share buyback. But both carmakers warned they needed to cut electric vehicle costs in the current financial year as they increase sales.

“Cost reduction remains our obsession,” said Renault’s chief executive Luca de Meo on Thursday, adding that the carmaker was aiming to reduce EV costs by 40 per cent, with plans to cut costs from petrol or hybrid models by 30 per cent by 2027.

Stellantis’s finance chief Natalie Knight said profits from electric models remained “lower than on [internal combustion engine] vehicles”, which “does have an effect on margins”. She added that the carmaker, which owns Jeep, Ram and Peugeot and is planning to launch eight electric models in the US this year, needed to cut costs.

She said a number of economic and political uncertainties meant the group was facing a “turbulent year”, despite the fact that falling interest rates and raw material costs are likely to help profits.

“The big challenges are a lot of macroeconomic developments, political developments, that keep things uncertain,” said Knight. “Most of those things are . . . outside of our control.”

Weaker Stellantis sales in North America as well as the impact of last autumn’s strikes saw margins across the whole company fall last year, dropping from 13.4 per cent to 12.8 per cent.

However net profit rose 11 per cent, to €18.6bn, on revenues that were 6 per cent higher at €189.5bn. The company also launched a €3bn share buyback on Thursday, sending shares to a record high in morning trading.

Renault shares rose by more than 6 per cent after it reported record operating margins of 7.9 per cent in 2023, and said it would boost its dividend to €1.85 per share, up from €0.25 the previous year.

However the company, which released earnings late on Wednesday, forecast lower margins of about 7.5 per cent in 2024. It said last year’s margins would have been lower, at 6.9 per cent, had it not been for some accounting effects from its combustion engines division, which will be phased out. The figure compared with a margin of 5.5 per cent in 2022.

Net income came in below analysts’ expectations at €2.2bn, but compared with a loss the previous year after the carmaker was hit with writedowns on its Russia exit.

Renault’s chief financial officer Thierry Piéton said 2024 would be a “breakthrough year” for the company’s electric car push even after it recently called off a stock market listing for its EV division Ampere.

“We mustn't fall into a complete depression on electric cars,” Piéton said on Wednesday evening. “There’ll certainly be some changes in the rhythm of adoption. But the train has left the station.”

WWD : Balenciaga to Add Second Flagship on Avenue Montaigne

Balenciaga to Add Second Flagship on Avenue Montaigne
The French house has also expanded its "creative headquarters" on nearby Avenue George V, where Cristóbal Balenciaga first set up his couture house in 1937.

PARIS – Expanding its profile in the Golden Triangle luxury shopping district of Paris, Balenciaga is to open a second flagship on Avenue Montaigne, WWD has learned.

Balenciaga chief executive officer Cédric Charbit confirmed the new store would open next year at No. 56, roughly across the street from its current flagship at No. 57.

“Our foundation and ambitions are further expanding,” he told WWD, noting the doubling of the brand’s presence on one of the toniest shopping streets in Paris is aimed at “reinforcing the house’s legacy.”

The imposing stone building at 56 Avenue Montaigne occupies a key chunk of the prestigious, tree-lined thoroughfare, flanked by large Gucci and Dolce & Gabbana boutiques, with Jacquemus sandwiched in between on one side. In the past, No. 56 housed separate boutiques for Jil Sander and Blumarine.

The boutique at 57 Avenue Montaigne opened in 2017 and was only the second store to open under creative director Demna, who arrived at the house’s creative helm in October 2015.

Additionally, Charbit told WWD that Balenciaga has completed its “grand return” to nearby Avenue George V, where founder Cristóbal Balenciaga first set up his couture house in 1937.

Last year the Kering-owned brand doubled the size of its couture salons at 10 Avenue George V by expanding to No. 12, adding new offices and commemorating the occasion with a plaque on the facade of the building explaining its historic significance.

Now it has completed the restoration and expansion of its “creative headquarters,” which now also spill over to No. 7 Avenue George V.

“The newly opened offices are high-tech while maintaining a respect for our tradition and craft,” Charbit said, calling the George V addresses “a place where Balenciaga’s past, present, and future live in sync.”

“It is important for Balenciaga, being such an important couture house, to have its creative ateliers, that are the heart of the house, its couture salons and its couture clients united all under one roof,” he added.

The creative headquarters house Demna‘s design studio and his teams, in addition to the Balenciaga couture and ready-to-wear ateliers. The iconic No. 10 address is dedicated entirely to couture.

“Over the past nine years we have undertaken the important and symbolic mission to expand Balenciaga’s presence and legacy in Paris’ epicenter of French couture excellence,” Charbit explained. “Each year has been an important step towards continuing the legacy of Balenciaga.”

The company’s main corporate offices are located on Rue de Sèvres with parent Kering in the old Laennec hospital, a transporting and tranquil complex of 17th-century stone buildings arranged in cross formations. The fashion house boasts other offices on the Left Bank located on nearby Rue Vaneau.

The building at 10 Avenue George V also houses twin couture stores — one for men, one for women — selling Bang & Olufsen speaker bags for 8,500 euros alongside jewelry, footwear, sunglasses, and disquieting face shields developed in collaboration with Mercedes AMG F1 engineers.

The historic couture salons were painstakingly restored to the way they were before the founder retired from fashion and closed shop in 1968. The house resumed making high fashions in 2021, and Demna only shows couture once a year, during Paris Couture Week in July.

Last year Balenciaga doubled its presence on Rodeo Drive in Los Angeles and debuted a two-story venue at South Coast Plaza in Costa Mesa, Calif., as part of its U.S. retail push. It also recently opened boutiques in Hamburg, Germany; Vancouver, B.C.; Guadalajara, Mexico; Rio de Janeiro; Taipei, Taiwan; Detroit; Mumbai; Kuala Lumpur, Malaysia; Riyadh, Saudi Arabia; and Hong Kong Harbour City.

Earlier this month the company opened a two-level location in American Dream, the entertainment and retail center in East Rutherford, N.J. And, on Saturday, Balenciaga is to open its biggest store in the Middle East region, at the Mall of the Emirates in Dubai.

>>> Europe : Brokers Upgrades & Downgrades - 15th of February 2024 V2(+)

>>> Up
* Altri Raised to Buy at JB Capital Markets; PT 5.60 euros (+)
* Anora Group Oyj Raised to Buy at SEB Equities; PT 6.20 euros
* Biohit Raised to Buy at Inderes; PT 2.40 euros
* Deutsche Post AG Raised to Buy at Goldman; PT 53 euros
* Finnair Raised to Buy at Nordea
* IntegraFin Raised to Outperform at RBC; PT 330 pence
* Kingfisher Raised to Buy at Citi; PT 258 pence (from 210)
* Richemond PT raised to 150 from 140 at Kepler Cheuvreux
* Saint-Gobain Raised to Buy at Goldman; PT 87 euros
* Sampo Raised to Outperform at Mediobanca SpA; PT 49 euros
* Terveystalo Raised to Buy at SEB Equities; PT 9.30 euros
* Vaisala Raised to Accumulate at Inderes; PT 40 euros
* Wereldhave Raised to Reduce at AlphaValue/Baader

>>> Down
* Avance Gas Cut to Hold at Fearnley; PT 140 kroner (+)
* BW LPG Cut to Hold at Fearnley; PT 155 kroner (+)
* Gjensidige Cut to Underperform at Mediobanca SpA; PT 180 kroner
* Heineken Cut to Hold at HSBC; PT 90 euros
* Kingfisher Cut to Hold at Jefferies; PT 210 pence
* Neste Cut to Equal-Weight at Barclays; PT 33 euros
* PGE Cut to Neutral at Citi; PT 9.10 zloty
* Randstad Cut to Neutral at BNPP Exane (+)
* Taaleri Plc Cut to Reduce at Inderes; PT 10 euros
* Tauron Cut to Neutral at Citi; PT 3.80 zloty
* Tokmanni Cut to Reduce at Inderes; PT 15.50 euros

>>> Initiation
* ACS Rated New Overweight at Barclays; PT 46 euros
* Argenx ADRs Rated New Peerperform at Wolfe
* Argeo Rated New Buy at Clarksons; PT 4.70 kroner
* Ashtead Technology Rated New Buy at Stifel; PT 750 pence (+)
* Handelsbanken Rated New Underweight at Morgan Stanley
* Hochtief Rated New Overweight at Barclays; PT 123 euros
* Intermediate Capital Rated New Overweight at Morgan Stanley
* Nordea Bank Rated New Equal-Weight at Morgan Stanley
* Sacyr Rated New Overweight at Barclays; PT 4.10 euros
* Swedbank Rated New Underweight at Morgan Stanley
* Wendel Rated New Buy at Berenberg; PT 103 euros

>>> Call
* Goldman’s Bell Raises Stoxx 600 Target on Valuations, Growth
* Intermediate Capital Gets Overweight Rating at Morgan Stanley
* Swedbank, Handelsbanken Started Underweight at Morgan Stanley (+)
* Verallia Demand Weak, 2024 Ebitda Guidance Misses, Citi Says
* Wendel New Buy at Berenberg on Unprecedented Strategy Change